143 related articles for article (PubMed ID: 10676837)
1. Fever, rash, and pancytopenia following vancomycin rechallenge in the presence of ceftazidime.
Shahar A; Berner Y; Levi S
Ann Pharmacother; 2000 Feb; 34(2):263-4. PubMed ID: 10676837
[No Abstract] [Full Text] [Related]
2. Drug rash, eosinophilia, and systemic symptoms syndrome: Two pediatric cases demonstrating the range of severity in presentation--A case of vancomycin-induced drug hypersensitivity mimicking toxic shock syndrome and a milder case induced by minocycline.
Vinson AE; Dufort EM; Willis MD; Eberson CP; Harwell JI
Pediatr Crit Care Med; 2010 Jul; 11(4):e38-43. PubMed ID: 20407399
[TBL] [Abstract][Full Text] [Related]
3. Comparative safety of teicoplanin and vancomycin.
Wilson AP
Int J Antimicrob Agents; 1998 May; 10(2):143-52. PubMed ID: 9716291
[TBL] [Abstract][Full Text] [Related]
4. Ceftazidime in combination with glycopeptide antibiotic is an effective first-line therapy for patients undergoing high-dose therapy with autologous peripheral blood stem cell support.
Egerer G; Goldschmidt H; Streich N; Ehrhard I; Sonntag HG; Haas R
Support Care Cancer; 1999 Sep; 7(5):336-42. PubMed ID: 10483819
[TBL] [Abstract][Full Text] [Related]
5. Probable hypersensitivity reaction to vancomycin associating rash, fever and neutropenia.
Dauby N; Fink W; Seyler L; Luce S; Nouwynck C; Tas S; Jacobs F
Acta Clin Belg; 2012; 67(3):226-8. PubMed ID: 22897075
[TBL] [Abstract][Full Text] [Related]
6. Vancomycin-induced reversible pancytopenia and rash in a 16-month-old boy with osteomyelitis: A case report
.
Leng B; Yan G; Li T; Hou N
Int J Clin Pharmacol Ther; 2020 Apr; 58(4):242-246. PubMed ID: 32000885
[TBL] [Abstract][Full Text] [Related]
7. Fatal toxic epidermal necrolysis associated with ceftazidine and vancomycin therapy: a report of two cases.
Thestrup-Pedersen K; Hainau B; Al'Eisa A; Al'Fadley A; Hamadah I
Acta Derm Venereol; 2000; 80(4):316-7. PubMed ID: 11028879
[No Abstract] [Full Text] [Related]
8. A sixty-five-year-old man with rash, fever, and generalized weakness.
Bajaj P; Prematta MJ; Ghaffari G
Allergy Asthma Proc; 2011; 32(1):e1-3. PubMed ID: 21262091
[TBL] [Abstract][Full Text] [Related]
9. Case report of vancomycin-induced pancytopenia.
Gupta S; Sharma S; Menon N; Ahuja S; Dahdouh M
Rev Soc Bras Med Trop; 2016 Apr; 49(2):258-9. PubMed ID: 27192600
[TBL] [Abstract][Full Text] [Related]
10. Delayed hypersensitivity reaction to vancomycin.
Marik PE; Ferris N
Pharmacotherapy; 1997; 17(6):1341-4. PubMed ID: 9399623
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind trial comparing ceftobiprole medocaril with vancomycin plus ceftazidime for the treatment of patients with complicated skin and skin-structure infections.
Noel GJ; Bush K; Bagchi P; Ianus J; Strauss RS
Clin Infect Dis; 2008 Mar; 46(5):647-55. PubMed ID: 18225981
[TBL] [Abstract][Full Text] [Related]
12. Fever, rash and agranulocytosis.
Khan U; Hadid T
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28270401
[No Abstract] [Full Text] [Related]
13. Incompatibility of vancomycin and ceftazidime for intraperitoneal use.
Wazny LD; Blake PG
Perit Dial Int; 2002; 22(1):93-4. PubMed ID: 11929153
[No Abstract] [Full Text] [Related]
14. The importance of vancomycin in drug rash with eosinophilia and systemic symptoms (DRESS) syndrome.
Blumenthal KG; Patil SU; Long AA
Allergy Asthma Proc; 2012; 33(2):165-71. PubMed ID: 22525393
[TBL] [Abstract][Full Text] [Related]
15. [Vancomycin-induced DRESS syndrome: a case report].
Cariou ME; Kaabar M; Cailliez P; Lorléac'h A; Prades-Grandgirard N; Jacobzone-Lévêque C; Schmitt F
Ann Biol Clin (Paris); 2013; 71(2):190-5. PubMed ID: 23587585
[TBL] [Abstract][Full Text] [Related]
16. Red man syndrome adverse reaction following intravenous infusion of cefepime.
Panos G; Watson DC; Sargianou M; Kampiotis D; Chra P
Antimicrob Agents Chemother; 2012 Dec; 56(12):6387-8. PubMed ID: 22948884
[TBL] [Abstract][Full Text] [Related]
17. Drug rash with eosinophilia and systemic symptoms syndrome associated with clindamycin.
Tian D; Mohan RJ; Stallings G
Am J Med; 2010 Nov; 123(11):e7-8. PubMed ID: 20843501
[No Abstract] [Full Text] [Related]
18. Tolerability of teicoplanin in 117 hospitalized adults with previous vancomycin-induced fever, rash, or neutropenia: a retrospective chart review.
Hung YP; Lee NY; Chang CM; Lee HC; Wu CJ; Chen PL; Lee CC; Chung CH; Ko WC
Clin Ther; 2009 Sep; 31(9):1977-86. PubMed ID: 19843487
[TBL] [Abstract][Full Text] [Related]
19. Histamine release during rapid vancomycin administration.
Renz C; Lynch J; Thurn J; Moss J
Inflamm Res; 1998; 47 Suppl 1():S69-70. PubMed ID: 9561421
[No Abstract] [Full Text] [Related]
20. Aztreonam and ceftazidime: evidence of in vivo cross allergenicity.
Pérez Pimiento A; Gómez Martínez M; Mínguez Mena A; Trampal González A; de Paz Arranz S; Rodríguez Mosquera M
Allergy; 1998 Jun; 53(6):624-5. PubMed ID: 9689350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
